A doctor's career: from Saarland to New York and back
A doctor's career: from Saarland to New York and back
The career of Dr. Martina Sersch, a respected expert in the field of biotechnology and drug development, is characterized by remarkable achievements and exciting experiences. Dr. Sersch enjoyed a well -founded training as a doctor and has become a key figure in cancer research through her work in various international biotechnology companies, including Roche/Genentech. Her journey not only included Europe, but also led her to Asia and the United States, where she took on significant responsibility.
A highlight of her career was to take on a cancer medication by another pharmaceutical company for antitrust reasons. This shows not only your commitment to medical progress, but also your skill in dealing with regulatory challenges in the health sector. In addition, Dr. Sersch works in the main center of a large company in New York, where she could extend her responsibility worldwide after only one year.
international experiences and innovation operator
dr. Sersch was active as a former Asia Pacific leader for biosimilars in Shanghai. In this role, she was significantly involved in the co -development and approval of numerous cancer medication. Against the background of current trends in cancer therapy, this work is particularly relevant, since biologics and their biosimilars take an increasing proportion of the pharmaceutical market. According to an examination, biologics that represent complex molecular units are used in cancer therapy and supportive care, whereby their development can be expensive due to the sometimes extensive test procedures. By 2023, 29 biosimilars in the USA and 64 in Europe have already been approved, which underlines the trend towards reducing costs and improved accessibility.
The challenges in the industry are enormous: gaps in knowledge about biosimilars both for health service providers and patients can lead to uncertainty. In addition, information about biosimilars is crucial to facilitate their integration into clinical practice. Dr. In this context, Sersch also supported a Chinese biotech company that was noted at Nasdaq. Your practical experience and your network open up significant perspectives for the future of cancer treatment.
family and commitment during pandemic
privately motivated Dr. Sersch's return to Saarland during her mother's dementia disease, where she used Sabbaticals for family reasons. These personal experiences shaped their view of the challenges in healthcare and the need for better networking in times of crisis. During Coronapandemic, Dr. Sersch in particular challenged through their background knowledge of infectious diseases and their cooperation with the German consulate in Shanghai.
dr. Sersch also founded its own company that focuses on investors and companies in medication development and new therapy approaches in the USA and China. This initiative illustrates its tireless efforts to improve the quality of life of patients through innovative medical solutions and to beat the bridge between different health systems. They position their comprehensive expertise and the ability to navigate in a rapidly changing environment as the central actor of modern biotechnology.
In view of the growing challenges in the health sector, the commitment of Dr. Sersch A shining example of how individual careers can initiate positive changes in medicine, despite the complex framework. Your path, shaped by courage, creativity and outstanding skills, will continue to be a source of inspiration for many in the future.| Details | |
|---|---|
| Quellen | |